1. Home
  2. HALO vs CIEN Comparison

HALO vs CIEN Comparison

Compare HALO & CIEN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • HALO
  • CIEN
  • Stock Information
  • Founded
  • HALO 1998
  • CIEN 1992
  • Country
  • HALO United States
  • CIEN United States
  • Employees
  • HALO N/A
  • CIEN N/A
  • Industry
  • HALO Biotechnology: Biological Products (No Diagnostic Substances)
  • CIEN Telecommunications Equipment
  • Sector
  • HALO Health Care
  • CIEN Utilities
  • Exchange
  • HALO Nasdaq
  • CIEN Nasdaq
  • Market Cap
  • HALO 7.6B
  • CIEN 12.8B
  • IPO Year
  • HALO N/A
  • CIEN 1997
  • Fundamental
  • Price
  • HALO $75.81
  • CIEN $136.49
  • Analyst Decision
  • HALO Buy
  • CIEN Buy
  • Analyst Count
  • HALO 8
  • CIEN 15
  • Target Price
  • HALO $70.25
  • CIEN $115.39
  • AVG Volume (30 Days)
  • HALO 1.8M
  • CIEN 3.1M
  • Earning Date
  • HALO 10-30-2025
  • CIEN 09-04-2025
  • Dividend Yield
  • HALO N/A
  • CIEN N/A
  • EPS Growth
  • HALO 68.93
  • CIEN 3.32
  • EPS
  • HALO 4.37
  • CIEN 0.98
  • Revenue
  • HALO $1,178,672,000.00
  • CIEN $4,541,635,000.00
  • Revenue This Year
  • HALO $32.57
  • CIEN $19.58
  • Revenue Next Year
  • HALO $23.25
  • CIEN $16.23
  • P/E Ratio
  • HALO $17.40
  • CIEN $139.62
  • Revenue Growth
  • HALO 34.97
  • CIEN 12.97
  • 52 Week Low
  • HALO $42.01
  • CIEN $49.21
  • 52 Week High
  • HALO $77.60
  • CIEN $139.55
  • Technical
  • Relative Strength Index (RSI)
  • HALO 70.39
  • CIEN 82.72
  • Support Level
  • HALO $75.25
  • CIEN $90.00
  • Resistance Level
  • HALO $77.60
  • CIEN $138.35
  • Average True Range (ATR)
  • HALO 1.67
  • CIEN 5.00
  • MACD
  • HALO -0.36
  • CIEN 2.96
  • Stochastic Oscillator
  • HALO 70.66
  • CIEN 95.45

About HALO Halozyme Therapeutics Inc.

Halozyme Therapeutics Inc is a biotechnology company focused on developing and commercializing novel oncology therapies. The company seeks to create therapies focused on human enzymes that alter tumors. Halozyme focuses on developing its proprietary products in therapeutic areas with a focus on oncology, and licensing its technology to biopharmaceutical companies to collaboratively develop products. The company's operations are based in the United States, with minimal long-lived assets located internationally.

About CIEN Ciena Corporation

Ciena is a telecommunications equipment provider focused on optical transport technologies, with clients in a number of industries such as communication services providers, web-scale providers, cable operators, government, and large enterprises worldwide. The company provides equipment, software, and services that support transport, switching, aggregation, service delivery, and data traffic management.

Share on Social Networks: